نتایج جستجو برای: payers factors

تعداد نتایج: 1080329  

Journal: :Research in social & administrative pharmacy : RSAP 2014
Marie Smith Michelle L Cannon-Breland Susan Spiggle

BACKGROUND Health care reform initiatives are examining new care delivery models and payment reform alternatives such as medical homes, health homes, community-based care transitions teams, medical neighborhoods and accountable care organizations (ACOs). Of particular interest is the extent to which pharmacists are integrated in team-based health care reform initiatives and the related perspect...

Journal: :Health affairs 2011
Miriam J Laugesen Sherry A Glied

Higher health care prices in the United States are a key reason that the nation's health spending is so much higher than that of other countries. Our study compared physicians' fees paid by public and private payers for primary care office visits and hip replacements in Australia, Canada, France, Germany, the United Kingdom, and the United States. We also compared physicians' incomes net of pra...

Prescription decision making is a complicated phenomenon influenced by many factors including drug strength, the patient’s context, prescriber characteristics, health facilities, payment type and pharmaceutical marketing. To evaluate the associations between each influenced factor and drug prescription method of Iranian physicians, we conducted an exploratory research, utilizing a questionnaire...

Prescription decision making is a complicated phenomenon influenced by many factors including drug strength, the patient’s context, prescriber characteristics, health facilities, payment type and pharmaceutical marketing. To evaluate the associations between each influenced factor and drug prescription method of Iranian physicians, we conducted an exploratory research, utilizing a questionnaire...

Journal: :Circulation 2017
Gregory P Hess Pradeep Natarajan Kamil F Faridi Anna Fievitz Linda Valsdottir Robert W Yeh

BACKGROUND Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are a novel class of medications for patients with familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease requiring additional lipid lowering beyond dietary measures and statin use. Because of the drugs' high cost, rates of prescription approval by payers may be low. We aimed to identify payer...

Journal: :Health services research 2003
Gautam Gozvrisankaran Robert J Town

OBJECTIVE To estimate the effects of competition for both Medicare and HMO patients on the quality decisions of hospitals in Southern California. DATA SOURCE Secondary discharge data from the Office of Statewide Health Planning and Development for the State of California for the period 1989-1993. STUDY DESIGN Outcome variables are the risk-adjusted hospital mortality rates for pneumonia (es...

Journal: :Journal of Market Access & Health Policy 2014

Journal: :Value in Health 2011

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید